Experts discuss emergency medicine in space, where severe medical events and loss of crew life are significant risks during long-duration flights. Alternative CPR methods have been tested in microgravity experiments, showing a 'hand-stand' technique as the most effective method.
A study of 23,600 childhood cancer survivors found a decline in severe health problems occurring five or more years after diagnosis, with the largest decreases seen in Wilms' tumor and Hodgkin lymphoma. Advances in treatment have improved five-year survival rates from 58% to 84% today.
A new cancer medicine, larotrectinib, has demonstrated compelling evidence for treating a range of advanced cancers. The therapy, which targets TRK fusion proteins, resulted in responses in 76% of patients across 17 different types of cancer. After 12 months of treatment, 79% of responding patients remained progression-free.
Adding abiraterone acetate to standard hormonal therapy reduces the chance of death by 38% and doubles the median time until cancer worsens. Cancer growth is delayed by 18 months, but severe side effects like high blood pressure and liver enzyme abnormalities are more common with abiraterone.
Researchers developed a biocatalytic system to produce terephthalic acid from p-xylene using metabolically engineered E. coli, offering a greener alternative to traditional chemical methods. The resulting yield of 97 mol% demonstrates the feasibility of this bio-based technology for large-scale production.
Experts at Euroanaesthesia congress discuss good Samaritan laws in Europe and their implications for doctors. They emphasize the importance of a doctor's duty to help, even if they're not able to assist fully, and note that successful claims against doctors are practically unheard of.
A new genomic sequencing approach detected circulating tumor DNA at a high rate in 89% of patients, identifying genetic changes that can be matched to targeted therapies. The study found 73% of genetic changes in tumor samples were also detected in blood samples.
A retrospective study of 1,200 women found that pregnancy after breast cancer diagnosis did not increase the risk of cancer recurrence and death. However, survivors with estrogen receptor-positive tumors may want to consider their personal risk for recurrence when deciding how long to wait before becoming pregnant.
A web-based tool enables patients to report symptoms in real time, triggering alerts to clinicians, resulting in a median survival of 5 months longer. Patients experience improved quality of life and are able to tolerate chemotherapy longer.
Olaparib has been shown to improve progression-free survival compared to chemotherapy in patients with BRCA-related advanced breast cancer. The phase III OlympiAD trial demonstrates the efficacy of olaparib as a treatment option for this patient population.
A clinical trial of nearly 2,000 men shows that adding abiraterone acetate to standard therapy for high-risk, advanced prostate cancer lowers the relative risk of death by 37% and increases the 3-year survival rate to 83%. The treatment also reduces the chance of relapse by 70% and serious bone complications by 50%.
A global study analyzed six clinical trials with over 12,800 patients, finding that 3 months of chemotherapy was nearly as effective as 6 months in patients with lower recurrence risk and caused fewer side effects. The study suggests a new standard for personalized chemotherapy in colon cancer.
A French study of 1,944 patients with advanced cancer found that comprehensive genomic profiling can guide treatment choices and lead to higher survival rates. The study's results suggest that routine genomic testing may not benefit all patients but offers hope for personalized medicine.
In a phase III clinical trial, olaparib reduced cancer progression by 42%, delaying it by 3 months compared to standard chemotherapy. Tumors shrunk in about 60% of patients who received olaparib.
A study found that 74% of bed partners encouraged early bedtime or late wake times, which conflict with cognitive behavioral therapy for insomnia. Partners also made accommodations that affected their own functioning, leading to increased anxiety.
A study published in JAMA found that integrating electronic patient-reported outcomes into routine care led to a significant increase in survival among patients with metastatic cancer. The trial showed a median survival difference of 5 months between the electronic patient-reported symptom monitoring group and usual care.
The Natural Caesarean section technique is associated with increased breastfeeding rates and improved patient experience. It allows parents to be actively involved in the birth process, promoting bonding opportunities between mother and baby.
Ready-to-eat foods such as dairy products and fresh produce contain antibiotic-resistant bacteria, which can be directly consumed or contaminate kitchen surfaces. Organic produce had higher levels of resistance than dairy products.
A new millimeter-wave amplifier developed by Hiroshima University and Mie Fujitsu Semiconductor can operate at a power supply voltage of 0.5 V, significantly reducing energy consumption and increasing reliability. This technology has the potential to improve driver-assistance and self-driving capabilities in vehicles.
Researchers at MD Anderson Cancer Center present two combination therapies that significantly shrink metastatic brain tumors in over half of patients with stage IV melanoma. The trials demonstrate the feasibility of conducting clinical trials for these patients and offer new hope for those with brain metastases.
A reliable clinical assay can detect the Zika virus from semen samples with a limit of detection of 5 viral copies per mL of semen. This assay has been validated through experiments with 100 semen samples spiked with recombinant Accuplex ZIKV and tested for other viruses.
A new Zika virus vaccine has shown 100% protection in mice, utilizing the NS1 protein. The vaccine's effectiveness was demonstrated through a single-dose immunization strategy.
A new, disposable diagnostic patch effectively detects obstructive sleep apnea across all severity levels, with a clinical agreement rate of 87.4%. The SomnaPatch weighs less than one ounce and records various physiological parameters while being comfortable and easy to use.
A study found that vapour from a novel hybrid tobacco heating product and two standard THPs had little to no impact on human cells in lab-based biological tests. The results suggest these products could reduce smoking-related disease risks when compared to cigarette smoking.
Newborns of mothers with sleep apnea have a higher risk of congenital anomalies and resuscitation at birth, with a 26% increased risk. Babies of mothers with sleep apnea are more likely to be admitted to the ICU or special care nursery.
Researchers found decreasing rates of resistance to oxacillin and other antibiotics in Staphylococcus aureus, while ceftaroline remained highly active against MRSA. The study's findings suggest a potential decrease in the prevalence of community-acquired MRSA, highlighting the importance of monitoring antimicrobial resistance.
The European Society of Anaesthesiology and Intensive Care proposes new guidelines for in-flight cardiac arrest, highlighting the importance of emergency equipment and crew training. The guidelines aim to improve treatment recommendations and reduce fatalities in such cases.
A recent study found that cancer patients who reported their symptoms using a web-based survey lived five months longer than those who did not. The study, led by UNC Lineberger Comprehensive Cancer Center researcher Ethan Basch, showed a significant median overall survival benefit of 20 percent.